EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Multistrain probiotics modulate tau pathology and preserve visuospatial cognition in early cognitive impairment: A double-blind, randomized, placebo-controlled trial

Eun Hyun Seo iD, Sarang Kang, Seung-Gon Kim, Ja-Hae Kim, Hye-Jung Yoon, Kyu Yeong Choi, Hyung-Jun Yoon iD, Kun Ho Lee, Kang-Ho Choi iD

Journal of Alzheimer’s Disease · 2026

DOI: 10.1177/13872877261477084 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Alzheimer’s Disease, 2026. Verfasst von Eun Hyun Seo und 8 weiteren Autor:innen. Beteiligte Einrichtung: Gwangju Alzheimer's Disease and Related Dementia Cohort Research Center, Chosun University, Gwangju, Republic of Korea. Hauptthemen laut MEDLINE: Cognition, Cognitive Dysfunction, Probiotics, tau Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: Korea Health Industry Development Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The gut-brain axis is increasingly implicated in Alzheimer's disease (AD) pathogenesis.

Objective

To investigate whether a multistrain probiotic supplement is associated with changes in AD-related plasma biomarkers and cognitive function in older adults with early cognitive impairment.

Methods

In this randomized, double-blind, placebo-controlled trial, eighty-seven participants from the Gwangju Alzheimer's Disease and Related Dementias cohort were randomized to receive a multistrain probiotic (n = 40) or placebo (n = 47) for 24 weeks. Plasma phosphorylated tau 181 (pTau181), glial fibrillary acidic protein (GFAP), and neurofilament light chain (NfL) were evaluated at baseline and 24 weeks. Cognitive assessments included the Clinical Dementia Rating Sum of Boxes (CDR-SB), CERAD battery, Stroop test, and Rey-Osterrieth Complex Figure (ROCF). Analyses utilized linear mixed models and ANCOVA.

Results

Compared to placebo, the probiotic group exhibited a significant reduction in plasma pTau181 (p < 0.001). While GFAP and NfL remained stable with probiotics, the placebo group showed significant within-group increases (p = 0.014, p = 0.041). Clinically, the probiotic group demonstrated improved CDR-SB scores (p = 0.010), primarily driven by the memory domain. Probiotics were associated with improved performance in visuospatial construction tasks (Constructional Praxis, p = 0.036; ROCF copy, p = 0.027) and preserved constructional recall, whereas the placebo group exhibited significant decline (p = 0.025). No significant between-group differences were observed in Mini-Mental State Examination, verbal memory, or executive scores.

Conclusions

Multistrain probiotics modulated plasma tau and neuroinflammatory biomarkers, and selectively preserved visuospatial cognition in this study. These findings suggest the potential role of microbiota-targeted interventions as a non-pharmacological adjunct for early cognitive impairment, although further studies are required to confirm underlying mechanisms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CognitionCognitive DysfunctionProbioticstau ProteinsAgedAged, 80 and overFemaleHumansMaleBiomarkersDouble-Blind MethodGlial Fibrillary Acidic ProteinNeuropsychological Tests

Stichwörter der Autor:innen

Alzheimer's diseasegut-brain axismultistrain probioticstau pathologyvisuospatial cognition

Substanzen

BiomarkersGlial Fibrillary Acidic Proteintau Proteins

Autor:innen und Institutionen

  • Gwangju Alzheimer's Disease and Related Dementia Cohort Research Center, Chosun University, Gwangju, Republic of Korea.
  • Premedical Science, College of Medicine, Chosun University, Gwangju, Republic of Korea.
  • BK21-Four Educational Research Group for Age-Associated Disorder Control Technology, Chosun University, Gwangju, Republic of Korea.
  • Department of Neuropsychiatry, Chosun University Hospital, Gwangju, Republic of Korea.
  • Department of Nuclear Medicine, Chonnam National University Hospital and Medical School, Gwangju, Republic of Korea.
  • Department of Neurology, Chonnam National University Hospital and Medical School, Gwangju, Republic of Korea.

ORCID-Profile: Eun Hyun Seo, Hyung-Jun Yoon, Kang-Ho Choi

Förderung

  • Korea Health Industry Development Institute

Zitieren

APA

Seo, E. H., Kang, S., Kim, S. G., Kim, J. H., Yoon, H. J., Choi, K. Y., Yoon, H. J., Lee, K. H., & Choi, K. H. (2026). Multistrain probiotics modulate tau pathology and preserve visuospatial cognition in early cognitive impairment: A double-blind, randomized, placebo-controlled trial. Journal of Alzheimer’s Disease. https://doi.org/10.1177/13872877261477084

Vancouver

Seo EH, Kang S, Kim SG, Kim JH, Yoon HJ, Choi KY, et al. Multistrain probiotics modulate tau pathology and preserve visuospatial cognition in early cognitive impairment: A double-blind, randomized, placebo-controlled trial. Journal of Alzheimer’s Disease. 2026. doi:10.1177/13872877261477084

BibTeX
@article{Seo2026,
  author = {Seo, Eun Hyun and Kang, Sarang and Kim, Seung-Gon and Kim, Ja-Hae and Yoon, Hye-Jung and Choi, Kyu Yeong and Yoon, Hyung-Jun and Lee, Kun Ho and Choi, Kang-Ho},
  title = {Multistrain probiotics modulate tau pathology and preserve visuospatial cognition in early cognitive impairment: A double-blind, randomized, placebo-controlled trial},
  journal = {Journal of Alzheimer’s Disease},
  year = {2026},
  doi = {10.1177/13872877261477084}
}
Kostenlos starten →